SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Serapha Bio is raising $230 million through a private placement of capital stock in connection with the proposed merger, with approximately $138 million already funded in a Series A financing and $92 million expected to close concurrently with the merger closing.
View raw filing on EDGAR →In connection with the merger agreement, Boundless Bio announced a workforce reduction of approximately 75% of its workforce, with estimated one-time costs of $3.0–$5.0 million primarily for termination benefits and severance, substantially completed in Q3 2026.
View raw filing on EDGAR →In connection with the merger transaction, Oien was appointed as President and principal executive officer of Boundless Bio, replacing departing CEO Hornby, along with compensatory arrangements including transaction bonuses and acceleration of stock options.
View raw filing on EDGAR →Wendy's appointed Steven W. Cirulis as Chief Financial Officer and Chief Strategy Officer effective June 23, 2026, with a $675,000 base salary, 90% bonus target, and $1,650,000 annualized LTIP grant. Ken Cook departed the CFO role effective July 31, 2026, transitioning to an advisory capacity.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code on June 23, 2026 (Case No. 26-10989) in the U.S. Bankruptcy Court for the District of Delaware. The company will operate as a debtor-in-possession and has filed motions for first-day relief and debtor-in-possession financing.
View raw filing on EDGAR →In connection with its Chapter 11 bankruptcy proceedings, Sangamo entered into stalking horse asset purchase agreements, a mechanism used in bankruptcy proceedings to facilitate asset sales and disposition activities.
View raw filing on EDGAR →Sangamo disclosed the creation of a debtor-in-possession (DIP) financing facility of up to $30 million from Northridge ATM, LLC, which constitutes a new direct financial obligation subject to court approval.
View raw filing on EDGAR →The Board approved a restructuring eliminating approximately 51 roles (40% of workforce) with expected incremental expenses of $3.0–$4.0 million in severance and employee health benefits.
View raw filing on EDGAR →The filing discloses that the HSR Act waiting period for a previously announced merger between TruBridge and Inventurus Knowledge Solutions expired on June 22, 2026, removing a key closing condition. The merger involves Merger Sub merging with TruBridge, with TruBridge becoming a wholly owned subsidiary of Parent—a material change of control transaction. This is a significant milestone in the completion of a material acquisition/merger.
View raw filing on EDGAR →This Item 5.07 discloses the results of MiNK Therapeutics' Annual Meeting of Stockholders held on June 17, 2026, including the election of three Class II Directors (Garo Armen, Barbara Ryan, and John Holcomb) and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Agenus Inc.'s Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes for six proposals: election of Class II Directors (Garo Armen and Jennifer Buell), approval of amendments to equity plans, a stock option exchange program, advisory compensation vote, and auditor ratification. All proposals were approved by stockholders, with detailed vote tallies provided for each matter. This is a material governance event affecting investor understanding of board composition and equity incentive structure.
View raw filing on EDGAR →Stepstone Private Credit Fund LLC completed an unregistered sale of 10,650,045 LLC interests for $279.6 million pursuant to subscription agreements, relying on Section 4(a)(2), Regulation D, and Regulation S exemptions. This private placement materially affects the registrant's capitalization and ownership structure.
View raw filing on EDGAR →The filing discloses the Company's net asset value per share ($26.25 as of May 31, 2026), aggregate NAV ($2,536.7 million), portfolio fair value, debt outstanding, and the status of an ongoing private offering ($2,689.0 million raised to date toward a $10 billion target). These metrics are material to investors in the closed-end fund structure but do not constitute a discrete event fitting standard 8-K categories.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 19, 2026. The filing reports voting outcomes for two proposals: (1) election of eleven directors with detailed vote tallies for each nominee, and (2) advisory approval of named executive officer compensation. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects governance decisions and shareholder sentiment on board composition and executive compensation.
View raw filing on EDGAR →This news release announces the US Department of Energy's conditional commitment of up to US$17.5 billion in loan financing to support Westinghouse's procurement of long-lead items for up to 10 AP1000 nuclear reactors. While the DOE commitment is conditional and subject to satisfaction of technical, legal, environmental, and financial conditions, the announcement represents a material strategic development for Cameco's ownership stake in Westinghouse (acquired November 2023) and signals significant near-term business opportunities in reactor deployment and nuclear fuel supply. This is an operational/strategic milestone rather than a discrete M&A transaction, earnings release, or other named event type, making operational_other the most appropriate classification.
View raw filing on EDGAR →The filing discloses both a departure (James J. Lorenz retiring effective December 31, 2026) and an appointment (John T. Robson appointed Vice President – Energy Operations effective January 1, 2027). While both events are present, the principal forward-looking action and the substantive disclosure centers on the appointment of Robson to succeed Lorenz in a key operational role. The appointment is the material event that addresses continuity of leadership in Energy Operations.
View raw filing on EDGAR →Vista Credit Strategic Lending Corp. completed an unregistered sale of 147,178.274 shares of Class I and Class S common stock for $2,808,500 pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →The Company disclosed preliminary net asset value (NAV) per share of $19.08 as of May 31, 2026, along with total investments of $1.9 billion and a debt-to-equity ratio of 0.83x.
View raw filing on EDGAR →First Eagle Private Credit Fund held its 2026 Annual Meeting of Shareholders on June 17, 2026, with shareholders voting to elect two Class I trustees (Nancy Hawthorne and Patrick Coyne, each receiving 12,403,652 votes for with zero withheld) and ratify PricewaterhouseCoopers LLP as independent auditor (12,403,652 votes for, zero against, zero abstained).
View raw filing on EDGAR →First Eagle Private Credit Fund declared regular distributions to shareholders of $0.210 per share (gross) for both Class I and Class D common shares, with a record date of June 30, 2026 and a payment date of July 30, 2026.
View raw filing on EDGAR →Fiserv completed a public offering of €1 billion in aggregate principal amount of senior notes, consisting of €500 million 3.750% Notes due 2030 and €500 million 4.250% Notes due 2034, on June 23, 2026. This represents a material creation of direct financial obligations with defined interest rates and maturity dates.
View raw filing on EDGAR →FMC entered into Amendment No. 7 to its Fifth Amended and Restated Credit Agreement on June 16, 2026, which materially modifies the limitation on liens and releases security interests on collateral previously granted to secure obligations under the Credit Agreement. This amendment represents a material modification of the Company's direct financial obligations and credit arrangements, affecting collateral and lien restrictions.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of LeonaBio's 2026 Annual Meeting of Stockholders held on June 22, 2026. The filing presents final voting tallies for four proposals: election of three Class III directors (Kelly A. Romano, James A. Johnson, and Natalie Holles), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future say-on-pay votes (determined to be every 3 years). The disclosure includes vote counts, broker non-votes, and the Board's determination based on the results, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →IDEAYA held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on three proposals: election of three Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing reports the tabulated vote counts for each proposal.
View raw filing on EDGAR →Effective June 16, 2026, the Board elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as Lead Independent Director, representing material governance restructuring of board leadership and oversight roles.
View raw filing on EDGAR →William Go, M.D., Ph.D., Chief Medical Officer of Janux Therapeutics, departed on June 23, 2026, under a termination without "Cause" under the Company's Change in Control and Severance Benefit Plan. The disclosure centers on the departure of a named executive officer and the triggering of severance benefits, making this a clear executive departure event. The company's statement that the transition does not affect development strategy or clinical timelines is a standard mitigation statement but does not change the materiality of the CMO's departure.
View raw filing on EDGAR →The filing discloses both the departure of Nelson Haight as Executive Vice President and Chief Financial Officer and the appointment of Clinton Roeder to the same role, effective June 22, 2026. While both events are disclosed, the appointment of a new CFO with detailed compensation terms (base salary of $500,000, bonus target of 75%, and equity grants of approximately $500,000) is the forward-looking material event that would affect investor assessment of the company's leadership and financial management going forward. The appointment is the principal action the company is announcing to the market.
View raw filing on EDGAR →Pacific Gas & Electric amended its credit agreements on June 22, 2026, increasing aggregate commitments from $5.4 billion to $6.25 billion under Amendment No. 6 to its Credit Agreement (extending maturity to June 20, 2031) and amending its revolving credit facility (extending maturity to June 22, 2029) with modified pricing grids and collateral release terms. These material amendments expand the company's borrowing capacity and extend its debt maturity profile.
View raw filing on EDGAR →North Haven Private Income Fund LLC completed an unregistered sale of approximately 338,864 Class S units for $6.12 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →North Haven Private Income Fund LLC declared two distributions on June 22, 2026: a regular distribution of $0.1208 per unit and a special distribution of $0.0205 per unit, both payable on or around July 6, 2026.
View raw filing on EDGAR →Worthington Enterprises issued a news release reporting fourth quarter and full-year fiscal 2026 results, including net sales of $371.5M for Q4, net earnings of $48.1M, EPS of $0.97, segment performance, cash flow analysis, and forward guidance.
View raw filing on EDGAR →The Board appointed W. Bradley Southern as a director effective June 23, 2026, increasing authorized directors from 13 to 14. Mr. Southern brings extensive executive experience as former CEO and Chair of Louisiana-Pacific Corporation (1999–2026) and currently serves as chair of the Nashville Federal Reserve Bank branch.
View raw filing on EDGAR →The Board declared a quarterly cash dividend of $0.20 per share on June 23, 2026, payable on September 29, 2026, representing a 5% increase ($0.01 per share) compared to the prior quarter.
View raw filing on EDGAR →North Haven Private Income Fund A LLC completed an unregistered private placement of approximately 24,412 Class I units for $0.5 million at $19.81 per unit, pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →North Haven Private Income Fund A LLC declared two distributions on June 22, 2026: a regular distribution of $0.1393 per unit and a special distribution of $0.0372 per unit, both payable on or around July 6, 2026.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Olema's June 17, 2026 annual meeting of stockholders. The filing presents final voting tallies for three proposals: election of four Class III directors (all elected), advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The disclosure directly matches the shareholder_vote_results event type and is material to investors assessing governance and board composition.
View raw filing on EDGAR →The Board of Directors declared a quarterly cash dividend of $0.77 per share on Class A and Class B common stock, totaling approximately $127.9 million, payable on July 15, 2026.
View raw filing on EDGAR →LGAM Private Credit LLC sold approximately 263,964 Common Units for $5.2 million at $19.61 per unit pursuant to subscription agreements, relying on Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →The company declared a regular distribution to unitholders of $0.1389 per unit, payable July 6, 2026 to unitholders of record as of June 30, 2026.
View raw filing on EDGAR →Blackstone disclosed a preliminary estimate of revenue expected to be recorded related to realization activity for the period April 1–June 23, 2026, projecting total Realized Performance Revenues and Realized Principal Investment Income in excess of $500 million. While this is an intra-quarter update rather than a full earnings release, it constitutes a material disclosure of expected financial results for a significant portion of Q2 2026, announced via press release and furnished under Item 7.01 (Regulation FD Disclosure). The disclosure materially affects investor understanding of near-term revenue generation and is consistent with earnings-related guidance.
View raw filing on EDGAR →The Board approved amended compensation arrangements for non-employee directors, including increases to annual cash retainers (base retainer increased $5,000 to $80,000; committee chair retainers increased $2,500–$5,000; Board Chair retainer increased $5,000 to $60,000) and restricted stock unit awards (base award increased $15,000 to $140,000; Board Chair award increased $10,000 to $70,000). This is a material compensatory arrangement disclosure under Item 5.02(e), affecting director compensation structure and equity grants.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Apollo Debt Solutions BDC's Annual Meeting of Shareholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class II Trustees and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (FOR, WITHHELD, AGAINST, ABSTAIN, BROKER-NON-VOTE) are the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →NNN REIT entered into a First Amendment to its Term Loan Agreement on June 23, 2026, exercising a $200 million incremental term loan option that increases the aggregate facility size from $300 million to $500 million. This expansion of the company's senior unsecured term loan facility represents the creation of a new direct financial obligation, with amendments to pricing grids on both the term loan and revolving credit facility reflecting refinancing activity.
View raw filing on EDGAR →Cory Anderson was promoted from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook effective July 1, 2026. While the disclosure includes compensatory changes (salary increase to $425,000 and bonus target increase to 45%), the principal disclosed action is the promotion to a new executive officer role with expanded responsibilities. The appointment of a person to a higher executive position is the salient event, though the compensation component is secondary.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of MidCap Financial Investment Corporation's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for two proposals: election of two Class I Directors (Pearlman and Powell) and ratification of Deloitte & Touche LLP as independent auditor. The tabulated vote counts for each proposal are the core content of the filing, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on four proposals: election of three directors (Tracey Benford, David M. McCoy, and Robert B. Stewart, Jr.), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and ratification of KPMG LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →The disclosure concerns a revised, unsolicited tender offer from Zodiac Partners II to acquire all outstanding shares of DXL at $0.84 per share. The Board is actively evaluating this offer and will make a recommendation to stockholders. This constitutes a material acquisition activity (potential change of control) that would significantly affect investor assessment of the company's future, even though the offer remains unsolicited and under review.
View raw filing on EDGAR →Obsidian Energy announced an increase in its syndicated credit facility from $235 million to $275 million, a $40 million expansion. This represents a material amendment to an existing direct financial obligation (credit facility) that enhances the company's borrowing capacity and financial flexibility. While not a new debt issuance per se, the expansion of a credit facility constitutes a material creation or amendment of a direct financial obligation, which falls under debt_issuance. The company explicitly states this strengthens its financial position ahead of the Belly River acquisition closing.
View raw filing on EDGAR →On June 23, 2026, Willis Lease Finance Corp stockholders approved a three-for-one forward stock split (Proposal 2) at a reconvened Annual Meeting, with 6,151,386 votes in favor, 1,187,377 against, and 6,752 abstentions. The filing also confirms approval of all five 2026 proxy proposals with overwhelming shareholder support.
View raw filing on EDGAR →CBRE entered into a new $1 billion 364-day senior unsecured revolving credit facility on June 23, 2026, replacing its prior facility. The facility features SOFR-based pricing, a leverage ratio covenant, and a maturity date of June 22, 2027.
View raw filing on EDGAR →